Department of Infection Control, Mount Sinai Hospital, Toronto, Ontario.
Crit Care Med. 2010 Apr;38(4 Suppl):e38-42. doi: 10.1097/CCM.0b013e3181cd7bb2.
The emergence of 2009 pandemic influenza H1N1 has necessarily led to the rapid evolution of sensitive, specific, and high-throughput molecular diagnostic assays for this virus at the same time that clinical laboratories attempt to cope with increasing demands in the setting of resource limitations. This situation has given rise to testing algorithms focusing on priority, clinical relevance, and appropriate surveillance. We describe the current state of understanding around diagnostic testing and laboratory detection of 2009 H1N1 influenza A virus.
2009 年大流行性流感 H1N1 的出现必然导致针对该病毒的敏感、特异和高通量分子诊断检测方法的快速发展，与此同时临床实验室试图在资源有限的情况下应对需求的不断增加。这种情况导致了以优先级、临床相关性和适当监测为重点的测试算法。我们描述了当前对 2009 年甲型 H1N1 流感病毒诊断检测和实验室检测的理解。
